UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048268
Receipt number R000055005
Scientific Title Development of biomagnetism measuring method using tunnel magnetoresistive sensors
Date of disclosure of the study information 2022/07/05
Last modified on 2023/01/06 14:59:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of biomagnetism measuring method using tunnel magnetoresistive sensors

Acronym

Development of biomagnetism measuring method using tunnel magnetoresistive sensors

Scientific Title

Development of biomagnetism measuring method using tunnel magnetoresistive sensors

Scientific Title:Acronym

Development of biomagnetism measuring method using tunnel magnetoresistive sensors

Region

Japan


Condition

Condition

Normal subjects and patients with neurological disorders

Classification by specialty

Cardiology Neurology Pediatrics
Oto-rhino-laryngology Orthopedics Neurosurgery
Laboratory medicine Rehabilitation medicine Adult
Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To develop the measuring methods of biomagnetic fields using tunnel magnetoresistive sensors

Basic objectives2

Others

Basic objectives -Others

To develop the measuring methods of biomagnetic fields using tunnel magnetoresistive sensors

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Measurement of biomagnetic fields generated from the brain, heart, spine, and peripheral nerves

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

25 weeks-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Keeping rest when measuring biomagnetic fields

Key exclusion criteria

With metal or machine that is difficult to remove

Claustrophobia

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Nobukazu
Middle name
Last name Nakasato

Organization

Tohoku University School of Medicine

Division name

Department of epileptology

Zip code

980-8575

Address

2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi

TEL

022-717-7343

Email

hello_epi@epilepsy.med.tohoku.ac.jp


Public contact

Name of contact person

1st name Nobukazu
Middle name
Last name Nakasato

Organization

Tohoku University School of Medicine

Division name

Department of epileptology

Zip code

980-8575

Address

2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi

TEL

022-717-7343

Homepage URL


Email

hello_epi@epilepsy.med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Tohoku University School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tohoku University School of Medicine

Address

2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi

Tel

022-717-7343

Email

tohoku.epileptology@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 06 Month 28 Day

Date of IRB


Anticipated trial start date

2022 Year 08 Month 01 Day

Last follow-up date

2027 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Normal subjects are recruited on the website of the Department of Epileptology, Tohoku University School of Medicine.


Management information

Registered date

2022 Year 07 Month 04 Day

Last modified on

2023 Year 01 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055005